We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Multiplex Diagnostic Test Identifies Eighteen Common Respiratory Pathogens

By HospiMedica staff writers
Posted on 25 Sep 2007
A multiplex-formatted diagnostic test can identify the most common viruses and bacteria that cause respiratory infections in a single reaction tube.

Eleven different respiratory RNA viruses, two DNA viruses, and five pneumonia bacteria can be identified from samples including nasopharyngeal aspirates, nasopharyngeal swabs, and bronchoalveolar lavage.

Traditional tests, such as viral culture and Ag-Ab test, are laborious, time-consuming, and relatively expensive. More...
By enabling healthcare personnel to test for 18 different pathogens for a cost comparable to testing a single pathogen, the Seeplex 18-plex respiratory test changes the system of a ‘single pathogen, single test' testing regime and avoids the high false-positive/negative results associated with conventional multiplexing. The Seeplex 18-plex respiratory test performs multiplexing without cross-reactivity and achieves rapid test results at a minimal cost per test.

The microorganisms detected by the Seeplex test are influenza A virus; influenza B virus; human respiratory syncytial virus A; human respiratory syncytial virus B; human parainfluenzae virus 1; human parainfluenzae virus 2; human parainfluenzae virus 3; human Coronavirus 229E/Nl63; human Coronavirus OC43/HKU1; human Rhinovirus; human Enterovirus; human adenovirus; human Bocavirus; Legionella pneumophila; Streptococcus pneumoniae; Chlamydophila pneumoniae; Haemophilus influenzae; and Mycoplasma pneumoniae.

Developed by Seegene (Rockville, MD, USA), the Seeplex test is based on multiplexing polymerase chain reaction (PCR) technology. It enables healthcare personnel to rapidly determine whether a patient's respiratory ailment is caused by a virus or bacteria, and subsequently prescribe the best course of treatment whether an antibiotic, antiviral, or bed rest.

"Our new 18-plex Respiratory Test is what the clinical healthcare industry has been asking for--the ability to routinely test for a wide spectrum of respiratory pathogens in a single test, at the price of a single pathogen test,” stated Jong-Yoon Chun, founder and CEO, Seegene. "Like our other commercially available tests, notably the recently introduced 18-plex test for human Papillomaviruses, our new respiratory test is simply performed with one multiplex PCR in a single tube and capillary electrophoresis for automated detection of pathogens. These tests use Seegene's DPO [Dual Priming Oligo] primer system, ensuring test reproducibility, specificity, and sensitivity.


Related Links:
Seegene

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Enteral Feeding Pump
SENTINELplus
Imaging Table
Stille imagiQ2
Newborn Hearing Screener
ALGO 7i
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.